LATAM Women's HSDD Treatment Market Sees Steady Growth to $170 Million (3.8% CAGR)

June 19, 2025 02:43 PM PDT | By EIN Presswire
 LATAM Women's HSDD Treatment Market Sees Steady Growth to $170 Million (3.8% CAGR)
Image source: EIN Presswire

Hyposexual desire disorder (HSDD) in women is defined as deficiency or lack of sexual fantasies and desire of sexual activity. PORTLAND, OR, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- Allied Market Research recently said "LATAM women hypoactive sexual desire disorder treatment market by Treatment Type and Sales Channel: Regional Opportunity Analysis and Industry Forecast, 2019–2027," the LATAM women hypoactive sexual desire disorder treatment market size accounted for $131 million in 2019, and is expected to reach $170 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.

♦ 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 -
https://www.alliedmarketresearch.com/request-sample/7952

𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗜𝗺𝗽𝗮𝗰𝘁 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 (𝗣𝗿𝗲 & 𝗣𝗼𝘀𝘁) -

• Since announcements of the Covid-19 outbreak as a pandemic, several countries across the globe adopted lockdown and asked to observe social distancing as a preventive measure to curb the spread. This resulted in decline in logistic services.
• On the other hand, the majority of the healthcare professionals and systems focused their attention on treating Covid-19 patients. Thus, most of the HSDD patients had to reschedule their doctor appointments.

The market is divided into hospitals, clinics, and internet retailers based on the sales channel. In 2019, the hospitals sector led the market, accounting for nearly 50% of the total. However, the sector for clinics is anticipated to experience the highest CAGR of 6.7% over the course of the forecast period.

The treatment market for LATAM women with hypoactive sex desire disorder is examined across a number of areas, including Brazil, Argentina, Chile, Colombia, and the rest of LATAM. In 2019, the Brazilian market, which made up more than one-third of the market, held the largest stake. But from 2020 to 2027, the market in all of Argentina is anticipated to grow at the greatest CAGR of 7.7%.

♦ 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟐𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @
https://www.alliedmarketresearch.com/latam-hypoactive-sexual-desire-disorder-treatment-market/purchase-options

𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗿𝗲 -

• Aurobindo Pharma,
• Bristol-Myers Squibb Company,
• GlaxoSmithKline Plc,
• Mylan N.V.,
• Novartis AG,
• Palatin Technologies, Inc.,
• Sprout Pharmaceuticals, Inc.,
• Sun Pharmaceutical Industries Limited,
• Teva Pharmaceutical Industries Ltd., and
• Zydus Cadila.

Lockdowns had an adverse impact on every type of business in Latin America. For instance, non-essential businesses such as retail business that operate with a physical location with access to public were closed. Furthermore, non-essential construction was also halted, recreational and entertainment businesses such as gyms, movie theaters, art centers, race tracks, salon, and public & private social clubs were also closed under the lock downs. However, essential businesses such as grocery stores, chemist stores, hospitals, veterinary hospitals remained functional during lockdowns.

𝗞𝗲𝘆 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀 𝗼𝗳 𝗧𝗵𝗲 𝗦𝘁𝘂𝗱𝘆 -

• By treatment type, in terms of value, the bupropion segment dominated the market in 2019, and is anticipated to maintain its dominance throughout the forecast period
• By sales channel, the clinics segment is anticipated to grow with the highest CAGR throughout the forecast period.
• By treatment type, the bupropion segment accounted for more than half the share of the market in 2019.

♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/7952

𝗚𝗲𝗼𝗴𝗿𝗮𝗽𝗵𝗶𝗰 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 -

The LATAM Women Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)

• Europe (UK, Germany, France and the rest of Europe)

• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)

• Latin America (Brazil, Mexico, and the rest of Latin America)

• Middle East and Africa (GCC and rest of the Middle East and Africa)

𝗙𝗿𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆 𝗔𝘀𝗸𝗲𝗱 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀?

Q1. What is the total market value of LATAM Women Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Q2. Which are the top companies hold the market share in LATAM Women Hypoactive Sexual Desire Disorder (HSDD) Treatment Market?

Q3. Which is the most influencing segment growing in the LATAM Women Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Q4. What would be forecast period in the market report?

Q5. What is the market value of LATAM Women Hypoactive Sexual Desire Disorder (HSDD) Treatment Market in 2020?

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀 -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+ + 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next